Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) EBT Margin (2016 - 2025)

Historic EBT Margin for Dexcom (DXCM) over the last 17 years, with Q4 2025 value amounting to 27.05%.

  • Dexcom's EBT Margin rose 80700.0% to 27.05% in Q4 2025 from the same period last year, while for Dec 2025 it was 23.35%, marking a year-over-year increase of 57700.0%. This contributed to the annual value of 23.35% for FY2025, which is 57700.0% up from last year.
  • Dexcom's EBT Margin amounted to 27.05% in Q4 2025, which was up 80700.0% from 29.13% recorded in Q3 2025.
  • Over the past 5 years, Dexcom's EBT Margin peaked at 29.13% during Q3 2025, and registered a low of 0.92% during Q4 2021.
  • Over the past 5 years, Dexcom's median EBT Margin value was 17.53% (recorded in 2021), while the average stood at 16.59%.
  • In the last 5 years, Dexcom's EBT Margin tumbled by -261900bps in 2021 and then skyrocketed by 154200bps in 2022.
  • Over the past 5 years, Dexcom's EBT Margin (Quarter) stood at 0.92% in 2021, then soared by 1683bps to 16.34% in 2022, then surged by 46bps to 23.8% in 2023, then fell by -20bps to 18.98% in 2024, then surged by 43bps to 27.05% in 2025.
  • Its EBT Margin stands at 27.05% for Q4 2025, versus 29.13% for Q3 2025 and 20.84% for Q2 2025.